Bvf INC/Il: holdings and changes
Number 9 of the top 100 funds by copy return. Bvf INC/Il reported 47 US stocks worth $3.0B for the quarter ending 2026-09-30 and changed 4 new, 7 added, 15 trimmed and 1 sold since 2026-06-30.
Copy return, 4 quarters+82.2%
US 500, same time+14.5%
Size$3.0B
Stocks47
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| RVMD Revolution Medicines INC | TRIM -17% | 16.61% | $505M | 2,460,560 |
| KYMR Kymera Therapeutics INC | 14.24% | $433M | 3,872,052 | |
| GHRS Gh Research PLC | 6.68% | $203M | 8,650,158 | |
| MLTX Moonlake Immunot | 6.16% | $187M | 16,001,284 | |
| XNCR Xencor INC | TRIM -13% | 5.11% | $155M | 6,227,034 |
| NKTR Nektar Therapeutics | TRIM -11% | 4.25% | $129M | 2,134,007 |
| ALKS Alkermes PLC | ADD +32% | 3.79% | $115M | 2,847,100 |
| STOK Stoke Therapeutics INC | ADD +42% | 3.09% | $94M | 3,608,968 |
| TYRA Tyra Biosciences INC | ADD +186% | 3.03% | $92M | 4,215,886 |
| ZYME Zymeworks INC | TRIM -5% | 3.02% | $92M | 3,464,142 |
| CULLINAN ONCOL Cullinan Oncology INC | 2.90% | $88M | 5,750,683 | |
| GPCR Structure Therapeutics INC | TRIM -20% | 2.77% | $84M | 2,691,426 |
| PVLA Palvella Therapeutics INC Ne | TRIM -10% | 2.75% | $84M | 607,149 |
| KURA Kura Oncology INC | TRIM -21% | 2.36% | $72M | 6,690,108 |
| ACIU Ac Immune Sa | 1.71% | $52M | 19,822,436 | |
| GLUE Monte Rosa Therapeutics INC | TRIM -4% | 1.68% | $51M | 4,276,578 |
| ENTX Entera Bio LTD | ADD +603% | 1.63% | $50M | 17,052,893 |
| OLEMA PHARMACE Olema Pharmaceut | 1.50% | $46M | 5,295,893 | |
| CBIO Crescent Biopharma INC. | ADD +13% | 1.48% | $45M | 3,093,590 |
| FDMT 4d Molecular The | 1.36% | $41M | 2,879,289 | |
| IMCR Immunocore Holdings Limited | TRIM -5% | 1.23% | $37M | 1,230,909 |
| ANNX Annexon INC | TRIM -5% | 1.15% | $35M | 8,278,164 |
| MIRM Mirum Pharmaceuticals, INC. | TRIM -61% | 1.14% | $35M | 407,226 |
| SGMT Sagimet Biosciences INC. | ADD +40% | 1.14% | $35M | 3,500,000 |
| PYXS Pyxis Oncology INC | BUY | 0.91% | $28M | 11,826,140 |
| ABSI Absci Corporation | 0.84% | $25M | 2,361,674 | |
| ADAGIO THERAPE Adagio Therapeutics INC | 0.81% | $24M | 28,165,000 | |
| AVR Anteris Technologies Global | 0.77% | $23M | 3,000,000 | |
| FHTX Foghorn Therapeutics INC | 0.69% | $21M | 5,842,000 | |
| STRO Sutro Biopharma INC | 0.66% | $20M | 1,251,788 | |
| QTTB Q32 Bio INC. | 0.64% | $19M | 2,350,000 | |
| ALEC Alector INC Com | BUY | 0.61% | $19M | 10,046,206 |
| Tokai Pharmace Tokai Pharmaceuticals INC | 0.52% | $16M | 6,293,282 | |
| IRON Disc Medicine INC | TRIM -80% | 0.50% | $15M | 233,300 |
| AVTX Avalo Therapeutics INC | TRIM -56% | 0.46% | $14M | 907,406 |
| OKUR Onkure Therapeutics INC | ADD +25% | 0.36% | $11M | 4,045,278 |
| IMUX Immunic INC | 0.23% | $7M | 765,295 | |
| TCGX Tcgx Acquisition Corp | BUY | 0.21% | $6M | 500,000 |
| RACD Research Alliance Corp Iv | BUY | 0.19% | $6M | 500,000 |
| RACC Research Alliance Corp III | 0.18% | $5M | 500,000 | |
| MOLN Molecular Partners Ag | 0.17% | $5M | 1,353,968 | |
| IMA Imagenebio INC | 0.17% | $5M | 1,110,002 | |
| XFOR X4 Pharmaceuticals INC Com New | TRIM -29% | 0.15% | $5M | 1,576,624 |
| IVA Inventiva Sa | 0.08% | $2M | 686,040 | |
| TCRX Tscan Therapeutics INC | 0.06% | $2M | 5,564,290 | |
| ENGN Engene Therapeutics INC | 0.01% | $200k | 945,402 | |
| TENX Tenax Therapeutics INC | TRIM -99% | 0.00% | $0k | 25,000 |
| XOMA Corp Xoma Corp | SELL | 0% | was $323M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-06-30 → 2023-09-30 | -6.4% | -3.6% |
| 2023-09-30 → 2023-12-31 | +13.9% | +11.2% |
| 2023-12-31 → 2024-03-31 | +5.0% | +10.0% |
| 2024-03-31 → 2024-06-30 | -6.6% | +4.0% |
| 2024-06-30 → 2024-09-30 | +8.9% | +5.4% |
| 2024-09-30 → 2024-12-31 | -9.5% | +2.1% |
| 2024-12-31 → 2025-03-31 | -21.9% | -4.6% |
| 2025-03-31 → 2025-06-30 | +22.3% | +10.5% |
| 2025-09-30 → 2025-12-31 | +54.7% | +2.4% |
| 2025-12-31 → 2026-03-31 | +10.2% | -4.6% |
| 2026-03-31 → 2026-06-30 | +25.0% | +14.8% |
| 2026-06-30 → 2026-09-30 | -14.5% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP